Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

Completed

• Conditions: Thyroid Cancer; Lymph Node Metastases
• Interventions: Procedure: Thyroidecomt and lymphectomy

• Registration Number: NCT04274829
• Lead Sponsor: University of Cagliari

Brief Summary

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Primary Completion: 2018-01
• Status Verified: 2020-02
• Study Completion: 2020-02
• Study First Submitted: 2020-02-15
• Study First Submitted QC: 2020-02-15
• Last Update Submitted: 2020-02-15
• Study First Posted: 2020-02-18
• Last Update Posted: 2020-02-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Patients with papillary microcarcinoma of the thyroid

Exclusion Criteria

Patients with thyroid nodules > 1 cm; incomplete data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
PTMC	Thyroidecomt and lymphectomy	Patients with papillary microcarcinoma of the thyroid

Primary Outcome Measures

Name	Time	Method
Incidence of lymph node metastasis	1 year	To define the incidence of lymph node metastasis in patients with papillary microcarcinoma

Secondary Outcome Measures

Name	Time	Method
Predicrive factors of lymph node metastasis	1 year	To assesss predictive factors of lymph node metastasis

Trial Locations

Locations (1)

AOU Cagliari; 🇮🇹 Cagliari, CA, Italy